Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study;Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR

Revista Espanola de Cardiologia

Volumn 64, Issue 5, 2011, Pages 385-394

  Marrugat, Jaume ^a   Vila, Joan ^a   Baena Díez, José Miguel ^a,b,c   Grau, María ^a   Sala, Joan ^d   Ramos, Rafel ^c,e   Subirana, Isaac ^a,f   Fitó, Montserrat ^a,g   Elosua, Roberto ^a,f  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Centro de Atencion Primaria   (Spain)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e UNIVERSITY OF GIRONA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g Instituto de Salud Carlos III   (Spain)

Author keywords

Cardiovascular diseases; Coronary disease; Primary prevention; Risk function

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DATA BASE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION DISTRIBUTION; QUESTIONNAIRE;

ADULT; AGED; CALIBRATION; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPULATION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; SEX FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 79955606154     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.12.011     Document Type: Article

References (32)

1. Estudio de la Mortalidad en España.Área de Análisis Epidemiológico y Situación de Salud [Página web] Instituto de Salud Carlos III [citado 19 Feb 2010]. Disponible en: http://193.146.50.130/ raziel.php
2. Gil M, Helena Martí H, Elosua R, Grau M, Sala J, Masiá R, et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007;60:349-56.
3. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32-8. (Pubitemid 15109489)
4. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004;25:484-91. (Pubitemid 38524273)
5. 4th Joint Task Force. European guidelines for CHD prevention. Eur Heart J. 2007;28:2375-414.
6. Bartecchi C, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB, et al. Reduction in the Incidence of Acute Myocardial Infarction Associated With a Citywide Smoking Ordinance. Circulation. 2006;114:1490-6. (Pubitemid 44527004)
7. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004;148:16-26. (Pubitemid 38900476)
8. Wilson PW. Challenges to improve coronary heart disease risk assessment. JAMA. 2009;302:2369-70.
9. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham Coronary Heart Disease Prediction Scores. JAMA. 2001;286:180-8.
10. Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999;81:40-6. (Pubitemid 29113202)
11. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003;57:634-8. (Pubitemid 36930293)
12. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordon F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61. (Pubitemid 36527246)
13. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health. 2007;61:40-7. (Pubitemid 46114588)
14. San Vicente Blanco R, Pérez Irazusta I, Ibarra Amarica J, Berraondo Zabalegui I, Uribe Oyarbide F, Urraca García deMadinabeitia J, et al. Guía de Práctica Clínica sobre el manejo de los lípidos como factor de riesgo cardiovascular. Vitoria-Gasteiz: Osakidetza; 2008.
15. Rodríguez Ruíz T, Rigo Carratalá F, Mairata Bosch S, García Sánchez B, Escriche Erviti L, Fiol Gelabert F, et al. Riesgo cardiovascular: Guía de actuación en atención primaria. Gerència d'Atenció Primària de Mallorca. Palma: Ib-salut; 2006.
16. Baena Díez JM, Barcelo Colomer E, Ciurana Misol R, Franzi Sisó A, García Cerdán MR. Colesterol i risc coronari. Barcelona: Institut Català de la Salut; 2009. Disponible en: http://www.gencat.cat/ics/professionals/guies/colesterol/colesterol.htm
17. Marrugat J, Sala J, Elosua R, Ramos R, Baena-Díez JM. Prevención cardiovascular: avances y el largo camino por recorrer. Rev Esp Cardiol. 2010;63 Suppl 2:49-54.
18. Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masiá R, et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil. 2007;14:653-9.
19. Grau M, Subirana I, Elosua R, Fitó M, Covas MI, Sala J, et al. Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe. Prev Med. 2010;51:78-84.
20. Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med. 1991;10:585-98.
21. D'Agostino Sr RB, Nam BH. Evaluation of the performance of survival analysis models: discrimination and calibration measures. En: Balakrishnan N, Rao C, editors. Advances in survival analysis handbook of statistics, 23. Amsterdam: Elsevier; 2004. p. 1-25.
22. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791-8.
23. Pencina MJ, D'Agostino Sr RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation. 2009;119:3078-84.
24. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, et al. Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, Estudio DARIOS. Rev Esp Cardiol. 2011;64:295-304.
25. Braunwald E. Epilogue: What do clinicians expect from imagers? J Am Coll Cardiol. 2006;47 Suppl C:101-3.
26. Kerr AJ, Broad J, Wells S, Riddell T, Jackson R. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart. 2009;95:125-9.
27. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a metaanalysis. JAMA. 2008;300:197-208.
28. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-9. (Pubitemid 44969122)
29. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795-802.
30. Lutgens E, Van Suylen RJ, Faber BC, Gijbels MJ, Eurlings PM, Bijnens AP, et al. Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol. 2003;23:2123-30.
31. Heistad DD. Unstable coronary-artery plaques. N Engl JMed. 2003;349:2285-7. (Pubitemid 37509734)
32. Marrugat J, Elosua R, Aldasoro E, Tormo MJ, Vanaclocha H, Segura A, et al. Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. Eur J Epidemiol. 2004;19:831-9.